πŸ‡ΊπŸ‡Έ FDA
Patent

US 10364433

Modulation of AGPAT5 expression

granted A61KA61K31/397A61K31/713

Quick answer

US patent 10364433 (Modulation of AGPAT5 expression) held by The Regents of the University of California expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/397, A61K31/713, A61K45/06, A61P